Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCε

Cellular Signalling

Volumn 18, Issue 8, 2006, Pages 1279-1286

  Marín, Yarí E ^a   Namkoong, Jin ^a   Cohen Solal, Karine ^a   Shin, Seung Shick ^a   Martino, Jeffrey J ^a   Oka, Masahiro ^b   Chen, Suzie ^a  

^a RUTGERS UNIVERSITY   (United States)

^b KOBE UNIVERSITY   (Japan)

Author keywords

cAMP; ERK; Melanoma; mGluR1; PKC; Signaling

Indexed keywords

4 CARBOXY 2 METHYLPHENYLGLYCINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C EPSILON; QUISQUALIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CYCLIC AMP; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, DOMINANT; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; MELANOMA; MICE; MUTATION; ONCOGENES; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; PROTO-ONCOGENE PROTEINS B-RAF; QUISQUALIC ACID; RECEPTORS, METABOTROPIC GLUTAMATE;

ANIMALIA; MUS MUSCULUS; POLLACHIUS VIRENS;

EID: 33646372468     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2005.10.012     Document Type: Article

References (38)

1. Pollock P.M., Cohen-Solal K., Sood R., Namkoong J., Martino J.J., Koganti A., Zhu H., Robbins C., Makalowska I., Shin S.S., Marin Y., Roberts K.G., Yudt L.M., Chen A., Cheng J., Incao A., Pinkett H.W., Graham C.L., Dunn K., Crespo-Carbone S.M., Mackason K.R., Ryan K.B., Sinsimer D., Goydos J., Reuhl K.R., Eckhaus M., Meltzer P.S., Pavan W.J., Trent J.M., and Chen S. Nat. Genet. 34 (2003) 108
2. Marín Y.E., Namkoong J., Shin S.S., Raines J., Degenhardt K., White E., and Chen S. Neuropharmacology 49 (2005) 70
3. Conn P.J., and Pin J.-P. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205
4. Hermans E., and Challiss R.A. Biochem. J. 359 (2001) 465
5. Marín Y., and Chen S. J. Mol. Med. 82 (2004) 735
6. Berridge M.J. Nature 361 (1993) 315
7. Bosanac I., Michikawa T., Mikoshiba K., and Ikura M. Biochim. Biophys. Acta 1742 (2004) 89
8. Agell N., Bachs O., Rocamora N., and Villalonga P. Cell. Signal. 14 (2002) 649
9. Liebmann C. Cell. Signal. 13 (2001) 777
10. Soderling T.R. Trends Biochem. Sci. 24 (1999) 232
11. Aramori I., and Nakanishi S. Neuron 8 (1992) 757
12. Francesconi A., and Duvoisin R. J. Biol. Chem. 273 (1998) 5615
13. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della Rocca G.J., Lin F., Kawakatsu H., Owada K., Luttrell D.K., Caron M.G., and Lefkowitz R.J. Science 283 (1999) 655
14. Marinissen M.J., and Gutkind J.S. Trends Pharmacol. Sci. 22 (2001) 368
15. Pierce K.L., Luttrell L.M., and Lefkowitz R.J. Oncogene 20 (2001) 532
16. Ferraguti F., Baldani-Guerra B., Corsi M., Nakanishi S., and Corti C. Eur. J. Neurosci. 11 (1999) 2073
17. Thandi S., Blank J.L., and Challiss R.A. J. Neurochem. 83 (2002) 1139
18. Cohen C., Zavala-Pompa A., Sequeira J.H., Shoji M., Sexton D.G., Cotsonis G., Cerimele F., Govindarajan B., Macaron N., and Arbiser J.L. Clin. Cancer Res. 12 (2002) 3728
19. Satyamoorthy K., Li G., Gerrero M.R., Brose M.S., Volpe P., Weber B.L., Van Belle P., Elder D.E., and Herlyn M. Cancer Res. 63 (2003) 756
20. Oka M., Hitomi T., Okada T., Nakamura Si.S., Nagai H., Ohba M., Kuroki T., Kikkawa U., and Ichihashi M. Biochem. Biophys. Res. Commun. 5 (2002) 1109
21. Oka M., Okada T., Nakamura S., Ohba M., Kuroki T., Kikkawa U., Nagai H., Ichihashi M., and Nishigori C. FEBS Lett. 554 (2003) 179
22. Cohen-Solal K., Reuhl K.R., Ryan K.B., Roberts K.G., and Chen S. Pigment Cell Res. 14 (2001) 466
23. Bruno V., Battaglia G., Kingston A., O'Neill M.J., Catania M.V., Di Grezia R., and Nicoletti F. Neuropharmacology 38 (1999) 199
24. Kwon G., Pappan K.L., Marshall C.A., Schaffer J.E., and McDaniel M.L. J. Biol. Chem 279 (2004) 8938
25. Oka M., and Kikkawa U. Cancer Metastasis Rev. 24 (2005) 287
26. Oka M., Ogita K., Ando H., Horikawa T., Hayashibe K., Saito N., Kikkawa U., and Ichihashi M. J. Cell. Physiol. 3 (1996) 406
27. Seger R., and Krebs E.G. FASEB J. 9 (1995) 726
28. Busca R., Abbe P., Mantoux F., Aberdam E., Peyssonnauz C., and Ballotti R. EMBO J. 19 (2000) 2900
29. Pollock P., Harper U., Hansen K., Yudt L., Stark M., Robbins C., Moses T., Hostetter G., Wagner U., Kakareka J., Salem G., Pohida T., Heenan P., Duray P., Kallioniemi O., Hayward N., Trent J., and Meltzer P. Nat. Genet. 33 (2003) 19
30. Uribe P., Wistuba I.I., and Gonzalez S. Am. J. Dermatopathol. 25 (2003) 365
31. Cai H., Smola U., Wixler V., Eisenmann-Tappe I., Diaz-Meco M.T., Moscat J., Rapp U., and Cooper G.M. Mol. Cell. Biol. 17 (1997) 732
32. Ueffing M., Lovric J., Philipp A., Mischak H., and Kolch W. Oncogene 24 (1997) 2921
33. Yang C., and Kazanietz M.G. Trends Pharmacol. Sci. 24 (2003) 602
34. Kim J.Y., Yang M.S., Oh C.D., Kim K.T., Ha M.J., Kang S.S., and Chun J.S. Biochem. J. 337 (1999) 275
35. Gutkind J.S., Novotny E.A., Brann M.R., and Robbins K.C. Proc. Natl. Acad. Sci. 88 (1991) 4703
36. McJilton M.A., Van Sikes C., Wescott G.G., Wu D., Foreman T.L., Gregory C.W., Weidner D.A., Harris Ford O., Lasater Morgan A., Mohler J.L., and Terrian DM. Oncogene 39 (2003) 7958
37. Perletti G.P., Concari P., Brusaferri S., Marras E., Piccinini F., and Tashjian Jr. A.H. Oncogene 16 (1998) 3345
38. Myatt A., and Hill S.J. Prostate 64 (2005) 175